|
|
1 | (1) |
|
Part I General Aspects: Techniques and Overviews |
|
|
1 | (220) |
|
1 High-Throughput Approaches to Biomarker Discovery and Challenges of Subsequent Validation |
|
|
3 | (14) |
|
|
|
2 Mass Spectrometry for Biomarker Development |
|
|
17 | (32) |
|
|
|
|
|
|
3 Mass Spectrometry-Based Lipidomics for Biomarker Research |
|
|
49 | (26) |
|
|
|
|
4 Toxicogenomic and Pharmacogenomic Biomarkers for Drug Discovery and Personalized Medicine |
|
|
75 | (36) |
|
|
|
|
|
111 | (30) |
|
|
|
|
6 Flow Cytometry as Platform for Biomarker Discovery and Clinical Validation |
|
|
141 | (24) |
|
|
|
7 Biomarkers in Urine and Use of Creatinine |
|
|
165 | (22) |
|
|
|
|
8 Formalin-Fixed Paraffin-Embedded Tissue (FFPET) Sections for Nucleic Acid-Based Analysis in Biomarker Discovery and Early Drug Development |
|
|
187 | (34) |
|
|
|
|
|
Part II Specific Analytes and Their Application |
|
|
221 | (234) |
|
9 Macrophage Inflammatory Protein-1 Alpha (MIP-1 alpha)/CCL3: As a Biomarker |
|
|
223 | (28) |
|
|
|
|
10 Novel Prognostic Biomarker, Pfetin, in Gastrointestinal Stromal Tumors: Proteomics Study |
|
|
251 | (16) |
|
|
11 Pentraxin 3 as Biomarker |
|
|
267 | (24) |
|
|
|
|
|
12 Salivary Amylase as a Preoperative Marker of Anxiety in Perioperative Medicine |
|
|
291 | (22) |
|
|
|
|
|
13 Urinary Hydrogen Peroxide as Biomarker |
|
|
313 | (20) |
|
|
|
|
|
|
|
|
|
333 | (30) |
|
|
|
|
|
15 Guanylyl Cyclase C as a Biomarker |
|
|
363 | (20) |
|
|
|
|
16 Isoprostanes as Biomarkers of Disease and Early Biological Effect |
|
|
383 | (22) |
|
|
|
17 Cyclophilin A: Novel Biomarker for Oxidative Stress and Cardiovascular Diseases |
|
|
405 | (34) |
|
|
|
18 FABP3 as Biomarker of Heart Pathology |
|
|
439 | (16) |
|
|
|
|
Part III Pregnancy and Life Events |
|
|
455 | (90) |
|
19 Biomarkers in Neonatology |
|
|
457 | (26) |
|
|
|
20 Fetal Membranes: Potential Source of Preterm Birth Biomarkers |
|
|
483 | (48) |
|
|
|
|
|
21 Biomarkers of Menopause |
|
|
531 | (14) |
|
|
|
Part IV Nutrition, Metabolism and Environmental Health |
|
|
545 | (90) |
|
22 Urinary Markers in Nutritional Studies |
|
|
547 | (20) |
|
|
|
23 Biomarkers of Oxidative Stress in Blood |
|
|
567 | (28) |
|
|
|
|
24 1-Hydroxypyrene as a Biomarker for Environmental Health |
|
|
595 | (18) |
|
|
|
25 Urinary Biomarkers of Environmental Health: Jet Fuel |
|
|
613 | (22) |
|
|
|
|
Part V Cardiovascular System, Lung and Kidney |
|
|
635 | (320) |
|
26 Biomarkers After Pediatric Heart Surgery |
|
|
637 | (22) |
|
|
|
|
27 Biomarkers of Necrosis and Myocardial Remodeling |
|
|
659 | (30) |
|
|
Esteban Orenes-Pinero Diana Hernandez-Romero |
|
|
|
|
28 Chronic Heart Failure and Serum Collagen |
|
|
689 | (20) |
|
|
|
|
|
29 Galectin-3 in Cardiovascular Disease |
|
|
709 | (22) |
|
|
|
30 Natriuretic Peptides for Diagnosis, Prognosis, and Management of Heart Failure |
|
|
731 | (26) |
|
|
|
31 Serum Heat Shock Proteins as Novel Biomarker for Heart Failure and Cardiovascular Diseases |
|
|
757 | (26) |
|
|
|
|
|
|
|
32 YKL-40 as Biomarker: Focus on Cardiovascular Disease |
|
|
783 | (28) |
|
|
|
33 Use of Radiolabeled Compounds and Imaging as Cardiac Biomarkers |
|
|
811 | (30) |
|
|
|
|
|
34 Hemostatic Biomarkers: Future Prospects and Challenges |
|
|
841 | (20) |
|
|
35 Biomarkers in Chronic Obstructive Pulmonary Disease (COPD): Current Concerns and Future Prospects |
|
|
861 | (30) |
|
|
|
|
36 Soluble Klotho as Biomarker of Vascular Dysfunction in Chronic Kidney Disease |
|
|
891 | (28) |
|
|
|
|
|
|
37 Traditional and Proteomic Biomarkers of Autosomal Dominant Polycystic Kidney Disease (ADPKD) |
|
|
919 | (20) |
|
|
38 Urinary Exosomes as Potential Source for Identification of Biomarkers for Kidney Damage: Comparing Methodologies |
|
|
939 | (16) |
|
|
|
|
Part VI Brain, Neurology and Associated Conditions |
|
|
955 | (186) |
|
39 Biomarkers for Depression |
|
|
957 | (22) |
|
|
|
40 Biomarkers for Psychosis |
|
|
979 | (30) |
|
|
41 Biomarkers of Parkinson's Disease |
|
|
1009 | (22) |
|
|
|
|
42 Biomarker for Amyotrophic Lateral Sclerosis |
|
|
1031 | (22) |
|
|
43 Biomarkers for Phase Switches in Multiple Sclerosis |
|
|
1053 | (28) |
|
|
|
|
|
|
44 MicroRNAs as Brain Injury Biomarker |
|
|
1081 | (32) |
|
Nagaraja S. Balakathiresan |
|
|
|
|
|
|
|
45 S100B: Potential Biomarker for CNS Insult and Injury |
|
|
1113 | (28) |
|
|
|
Part VII Cancer, Immune Function, Inflammation and Other Conditions |
|
|
1141 | (168) |
|
46 Functionalized Gold Nanoparticles for Detection of Cancer Biomarkers |
|
|
1143 | (34) |
|
|
|
|
47 Biomarkers of Vector Bites: Arthropod Immunogenic Salivary Proteins in Vector-Borne Diseases Control |
|
|
1177 | (30) |
|
|
|
|
|
|
|
|
|
|
48 Inflammasome Proteins as Biomarkers of Injury and Disease |
|
|
1207 | (22) |
|
Juan Pablo de Rivero Vaccari |
|
|
Juan Carlos de Rivero Vaccari |
|
|
49 Lower Urinary Tract Disease and Their Objective and Noninvasive Biomarkers |
|
|
1229 | (22) |
|
|
|
50 Seasonal Allergic Rhinitis and Systems Biology-Oriented Biomarker Discovery |
|
|
1251 | (26) |
|
|
|
|
51 Biomarkers of Graft-Versus-Host Disease |
|
|
1277 | (32) |
|
|
|
|
Part VIII Further Knowledge |
|
|
1309 | (8) |
|
52 Biomarkers in Health and Disease: Further Knowledge |
|
|
1311 | (6) |
|
|
|
|
Index |
|
1317 | |